Memorial Sloan Kettering Cancer Center (MSK) is the world’s oldest and largest private cancer center. For more than 135 years, the cancer experts at MSK have kept patients at the center of everything we do, from caring for the people we treat to pioneering innovative research and outstanding educational programs.
MSK aims to prevent, control, and ultimately cure cancer. That is the shared commitment of our more than 1,400 doctors, 4,000 nurses, and over 14,500 support staff.
For more than three decades, MSK has been consistently rated as one of one of the top 2 cancer hospitals in the nation by U.S. News & World Report, the most recognized ranking of healthcare facilities in America. We are also a charter member of the National Cancer Institute’s designated Comprehensive Cancer Centers.
Exceptional Patient Care and Cancer Expertise
There are more than 400 different types of common and rare cancer, each requiring the expertise of specialists to provide the best possible care. Our world-class experts are organized into multidisciplinary teams, and the members of each team specialize in treating one type of cancer. This means that the physicians and other healthcare professionals caring for you can develop a plan for the combination of treatments that will lead to the best possible outcome for you.
Lifesaving Cancer Innovations
MSK scientists and doctors have developed many of today’s most important advances in treating cancer. In the field of immunotherapy, studies began at MSK more than a century ago. Since then, our scientists have been working to discover and improve treatments that use your body’s own immune system to fight cancer cells, much in the same way that it attacks bacteria or viruses. Our research is changing the way doctors treat melanoma, leukemia and lymphoma, lung, bladder, kidney, and many other cancers.
MSK in India
We are proud to include India in our mission of advancing patient care, research, and education. Our new center in Chennai is a first of its kind not only for our institution, but for the 1.5 million families in India who are affected by cancer every year.
Through remote consultations, our center provides people across India with direct access to our expert oncologists, surgeons, and other specialists in New York. In collaboration with iCliniq, a leading global telemedicine provider, our India-based team helps patients and their families access our doctors for comprehensive second opinions, video and written consults, and if clinically advisable, for in-person care at MSK in New York.
Sir Murray F. Brennan, GNZM, MD, FACS
Senior Vice President of International Programs; Benno C. Schmidt Chair in Clinical Oncology
Associate Director, International Center